{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:36:11Z","timestamp":1772850971080,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bioorg.2020.104504","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T12:32:35Z","timestamp":1606221155000},"page":"104504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["5-[Aryloxypyridyl (or nitrophenyl)]-4H-1,2,4-triazoles as novel flexible benzodiazepine analogues: Synthesis, receptor binding affinity and lipophilicity-dependent anti-seizure onset of action"],"prefix":"10.1016","volume":"106","author":[{"given":"Latifeh","family":"Navidpour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabnam","family":"Shabani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manouchehr","family":"Bashiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azadeh","family":"Ebrahim-Habibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Shahhosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Shafaroodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayyed","family":"Abbas Tabatabai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Toolabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.104504_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/jm00187a001","article-title":"The Benzodiazepine Story","volume":"22","author":"Sternbach","year":"1979","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104504_b0010","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0832-5","article-title":"GABAA receptor signalling mechanisms revealed by structural pharmacology","volume":"565","author":"Masiulis","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.104504_b0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-0404.2008.01004.x","article-title":"Benzodiazepines in epilepsy: pharmacology and pharmacokinetics","volume":"118","author":"Riss","year":"2008","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bioorg.2020.104504_b0020","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.2147\/NDT.S164307","article-title":"Valium without Dependence? Individual GABAA Receptor Subtype Contribution toward Benzodiazepine Addiction, Tolerance, and Therapeutic Effects","volume":"14","author":"Cheng","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bioorg.2020.104504_b0025","first-page":"5773","article-title":"Design and Identification of a Novel, Functionally Subtype Selective GABAA Positive Allosteric Modulator (PF-06372865)","volume":"62","author":"Owen","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104504_b0030","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1021\/acs.jmedchem.9b01312","article-title":"Subtype Selective \u03b3-Aminobutyric Acid Type A Receptor (GABAAR) Modulators Acting at the Benzodiazepine Binding Site: An Update","volume":"63","author":"Maramai","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104504_b0035","first-page":"165","article-title":"Recent Advances in the molecular pharmacology of benzodiazepine receptors and in the structure activity relationships of their agonists and antagonists","volume":"14","author":"Haefely","year":"1985","journal-title":"Adv. Drug Res."},{"key":"10.1016\/j.bioorg.2020.104504_b0040","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0024-3205(91)90533-H","article-title":"Molecular models for recognition and activation at the benzodiazepine receptor: a review","volume":"48","author":"Villar","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2020.104504_b0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0026-895X(25)10983-8","article-title":"Modeling of Benzodiazepine Receptor Binding Site by the General Three-Dimensional Structure-Directed Quantitative Structure-Activity Relationship Method REMOTEDISC","volume":"37","author":"Ghose","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.104504_b0050","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1021\/jm00032a007","article-title":"Synthesis of benzo-fused benzodiazepines employed as probes of the agonist pharmacophore of benzodiazepine receptors","volume":"37","author":"Zhang","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104504_b0055","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1021\/jm00010a013","article-title":"Synthesis of Novel Imidazobenzodiazepines as probes of the Pharmacophore for \u201cDiazepam-Intensive\u201d GABAA Receptors","volume":"38","author":"Zhang","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104504_b0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0026-895X(25)13502-5","article-title":"Molecular Structure of Ro 15\u20131788 and Model for the Binding of Benzodiazepine Ligands. Structural Identification of Common Features in Antagonists","volume":"28","author":"Codding","year":"1985","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.104504_b0065","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/0024-3205(86)90318-8","article-title":"Conformational Shifts at the Benzodiazepine Receptor Related to the Binding of Agonists Antagonists, and Inverse Agonists","volume":"39","author":"Fryer","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2020.104504_b0070","first-page":"269","article-title":"Model of the BzR Binding Site: Correlation of Data From Site-Directed Mutagenesis and the Pharmacophore\/Receptor Model","volume":"10","author":"He","year":"2001","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2020.104504_b0075","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0024-3205(91)90005-V","article-title":"Synthetic and Computer Assisted Analysis of Pharmacophore for Agonists at Benzodiazepine Receptors","volume":"49","author":"Diaz-Arauzo","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2020.104504_b0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-018-0833-4","article-title":"Cryo-EM structure of the human \u03b11\u03b23\u03b32 GABAA receptor in a lipid bilayer","volume":"565","author":"Laverty","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2020.104504_b0085","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0968-0896(02)00469-8","article-title":"Design and synthesis of 4H\u20133-(2-phenoxy)phenyl-1,2,4-triazole derivatives as benzodiazepine receptor agonists","volume":"11","author":"Akbarzadeh","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104504_b0090","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1016\/j.bmcl.2004.09.072","article-title":"Synthesis and anticonvulsant activity of new 2-substituted-5-[2-(2-fluorophenoxy)phenyl]1,3,4-oxadiazoles and 1,2,4-triazoles","volume":"14","author":"Almasirad","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104504_b0095","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.bmcl.2005.02.014","article-title":"Synthesis and anti-convulsant activity of new 2-substituted-5-(2-benzyloxyphenyl)-1,3,4-oxadiazoles","volume":"15","author":"Zarghi","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104504_b0100","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ardp.200900294","article-title":"Design and Synthesis of 2-Phenoxynicotinic Acid Hydrazides as Anti-inflammatory and Analgesic Agents","volume":"343","author":"Moradi","year":"2010","journal-title":"Archiv der Pharmazie."},{"key":"10.1016\/j.bioorg.2020.104504_b0105","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.bmc.2014.01.041","article-title":"Synthesis, receptor affinity and effect on pentylenetetrazole-induced seizure threshold of novel benzodiazepine analogues: 3-Substituted 5-(2-phenoxybenzyl)-4H-1,2,4-triazoles and 2-amino-5-(phenoxybenzyl)-1,3,4-oxadiazoles","volume":"22","author":"Mashayekh","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104504_b0110","series-title":"Miller's Anesthesia","author":"Miller","year":"2014"},{"key":"10.1016\/j.bioorg.2020.104504_b0115","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.nucmedbio.2013.06.010","article-title":"Comparison [3H]-flumazenil binding parameters in rat cortical membrane using different separation methods, filtration and centrifugation","volume":"40","author":"Ahmadi","year":"2013","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.bioorg.2020.104504_b0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.farmac.2003.11.013","article-title":"lipophilic 4-imidazolyl-1,4-dihydropyridines: synthesis, calcium channel antagonist activity and protection against pentylenetetrazole-induced seizure","volume":"59","author":"Navidpour","year":"2004","journal-title":"Il Farmaco"},{"key":"10.1016\/j.bioorg.2020.104504_b0125","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neuropharm.2004.04.011","article-title":"The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice","volume":"47","author":"Shafaroodi","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bioorg.2020.104504_b0130","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/bioinformatics\/btu426","article-title":"YASARA View\u2014molecular graphics for all devices\u2014from smartphones to workstations","volume":"30","author":"Krieger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bioorg.2020.104504_b0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2020.104504_b0140","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD\u2013Visual Molecular Dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graphics"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820318022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820318022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:14:11Z","timestamp":1758615251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820318022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":28,"alternative-id":["S0045206820318022"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104504","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-[Aryloxypyridyl (or nitrophenyl)]-4H-1,2,4-triazoles as novel flexible benzodiazepine analogues: Synthesis, receptor binding affinity and lipophilicity-dependent anti-seizure onset of action","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104504"}}